Aloenin aglycone is an NF-κB inhibitor that suppresses TNFα-induced NF-κB transcriptional activity (IC50: 18.7 μM); it also downregulates the expression of inducible nitric oxide synthase (iNOS) and intercellular adhesion molecule 1 (ICAM-1) genes in HepG2 cells stimulated with TNFα.